Showing results (181-190 of 197) with videos related to
Sort By:
Pageof 20
The Korean Journal of Internal Medicine|August 18, 2022
Safety and effectiveness of direct-acting antivirals in patients with chronic hepatitis C and chronic kidney diseaseJi Eun Ryu, Myeong Jun Song, Seok-Hwan Kim, et al.Gut and Liver|April 11, 2025
Predicting Mortality and Cirrhosis-Related Complications with MELD3.0: A Multicenter Cohort AnalysisJihye Lim, Ji Hoon Kim, Ahlim Lee, et al.Journal of Clinical Medicine|October 13, 2021
The Role of Urinary N-Acetyl-β-d-glucosaminidase in Cirrhotic Patients with Acute Kidney Injury: Multicenter, Prospective Cohort StudyJeong-Ju Yoo, Jung Hyun Kwon, Young Seok Kim, et al.Journal of Medical Virology|January 30, 2019
Clinical outcomes after the introduction of direct antiviral agents for patients infected with genotype 1b hepatitis C virus depending on the regimens: A multicenter study in KoreaJung Hyun Kwon, Sun Hong Yoo, Soon Woo Nam, et al.Hepatology International|October 13, 2023
New prognostic model for hospitalized patients with alcoholic cirrhosis and Maddrey's discriminant function <32Tae Hyung Kim, Hyung Joon Yim, Young Kul Jung, et al.Journal of Clinical Gastroenterology|January 26, 2018
Long-term Prognosis of Acute-on-Chronic Liver Failure SurvivorsEileen L Yoon, Tae Yeob Kim, Chang Hyeong Lee, et al.Journal of Gastroenterology and Hepatology|May 9, 2024
Validation of MELD 3.0 in patients with alcoholic liver cirrhosis using prospective KACLiF cohortJihye Lim, Jung Hee Kim, Sung-Eun Kim, et al.Cancers|September 9, 2023
A Real-World Comparative Analysis of Atezolizumab Plus Bevacizumab and Transarterial Chemoembolization Plus Radiotherapy in Hepatocellular Carcinoma Patients with Portal Vein Tumor ThrombosisSoon Kyu Lee, Jung Hyun Kwon, Sung Won Lee, et al.Digestive Diseases and Sciences|February 7, 2019
Efficacy and Safety of Tenofovir Disoproxil Fumarate in Treatment-Naïve Patients with Chronic Hepatitis B in KoreaJung Hyun Kwon, Myeong Jun Song, Jeong Won Jang, et al.Hepatology (Baltimore, Md.)|June 30, 2025
Development and validation of a risk prediction model for patients with hepatocellular carcinoma receiving atezolizumab-bevacizumabHeechul Nam, Dong Yun Kim, Do Young Kim, et al.Pageof 20